Loperamide Hydrochloride; Simethicone was first introduced by Johnson And Johnson Consumer Inc Mcneil Consumer Healthcare Div in its drug Imodium Multi-Symptom Relief on Jun 26, 1996. 10 different companies have introduced drugs containing Loperamide Hydrochloride; Simethicone.

Loperamide Hydrochloride; Simethicone Patents

Given below is the list of patents protecting Loperamide Hydrochloride; Simethicone, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Imodium Multi-symptom Relief	US6103260	Simethicone/anhydrous calcium phosphate compositions	Jul 17, 2017 (Expired)	Kenvue Brands
Imodium Multi-symptom Relief	US5679376	Simethicone containing pharmaceutical compositions	Oct 21, 2014 (Expired)	J And J Consumer Inc
Imodium Multi-symptom Relief	US5489436	Taste mask coatings for preparation of chewable pharmaceutical tablets	Feb 06, 2013 (Expired)	J And J Consumer Inc

Add above patents to watchlist

Loperamide Hydrochloride; Simethicone's Family Patents

Full family tree

Loperamide Hydrochloride; Simethicone Generic API Manufacturers

Several generic applications have been filed for Loperamide Hydrochloride; Simethicone. The first generic version for Loperamide Hydrochloride; Simethicone was by L Perrigo Co and was approved on Aug 30, 2002. And the latest generic version is by Granules India Ltd and was approved on Aug 29, 2022.

Given below is the list of companies who have filed for Loperamide Hydrochloride; Simethicone generic, along with the locations of their manufacturing plants worldwide.